Pacira BioSciences (PCRX) Goodwill & Intangibles (2010 - 2026)
Pacira BioSciences (PCRX) recorded quarterly Goodwill & Intangibles of $373.0 million in Q1 2026, down 3.93% quarter-over-quarter from $388.3 million in Q4 2025, and down 18.28% on a YoY basis from $456.5 million in Q1 2025.
Pacira BioSciences (PCRX) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Pacira BioSciences' Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $373.0 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 18.28% year-over-year to $373.0 million; the TTM figure through Mar 2026 stood at $373.0 million (down 18.28% YoY), while the FY2025 annual figure was $388.3 million, down 8.84% from the prior year.
- Goodwill & Intangibles was $373.0 million for Q1 2026 at Pacira BioSciences, down from $388.3 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $755.3 million in Q1 2022 to a low of $373.0 million in Q1 2026.
- Historically, Goodwill & Intangibles has averaged $575.9 million across 5 years, with a median of $632.1 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles jumped 289.25% in 2022, then sank 34.11% in 2024.
- A 5-year view of Goodwill & Intangibles shows it stood at $703.8 million in 2022, then declined by 8.14% to $646.5 million in 2023, then tumbled by 34.11% to $426.0 million in 2024, then dropped by 8.84% to $388.3 million in 2025, then fell by 3.93% to $373.0 million in 2026.
- The last three Goodwill & Intangibles figures came in at $373.0 million (Q1 2026), $388.3 million (Q4 2025), and $402.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Pacira BioSciences | 935.46 Mn | 733.28 Mn | 140.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 373.03 Mn |
| Dec 31, 2025 | 388.30 Mn |
| Sep 30, 2025 | 402.71 Mn |
| Jun 30, 2025 | 442.86 Mn |
| Mar 31, 2025 | 456.49 Mn |
| Dec 31, 2024 | 425.97 Mn |
| Sep 30, 2024 | 440.29 Mn |
| Jun 30, 2024 | 617.81 Mn |
| Mar 31, 2024 | 632.14 Mn |
| Dec 31, 2023 | 646.50 Mn |
| Sep 30, 2023 | 660.82 Mn |
| Jun 30, 2023 | 675.10 Mn |
| Mar 31, 2023 | 689.42 Mn |
| Dec 31, 2022 | 703.79 Mn |
| Sep 30, 2022 | 738.40 Mn |
| Jun 30, 2022 | 741.42 Mn |
| Mar 31, 2022 | 755.35 Mn |
| Dec 31, 2021 | 769.17 Mn |
| Sep 30, 2021 | 190.17 Mn |
| Jun 30, 2021 | 192.09 Mn |